BAXS Insider Trading Activity and SEC Form 4 Filings
BAXS insider trading summary
No open-market insider purchases or sales of Baxano Surgical, Inc. (BAXS) have been reported on SEC Form 4 in the past 12 months.
Latest BAXS insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Aug 15, 2014 | Kenneth Michael Reali | President and CEO | Buy | $4K (10,000 @ $0.38) |
| May 12, 2014 | Kenneth Michael Reali | President and CEO | Buy | $4K (5,719 @ $0.70) |
| May 12, 2014 | Kenneth Michael Reali | President and CEO | Buy | $962 (1,331 @ $0.72) |
| Dec 5, 2013 | Kenneth Michael Reali | President & CEO | Buy | $12K (10,500 @ $1.11) |
| May 31, 2013 | Roderick A Young | Director | Buy | $66K (28,948 @ $2.28) |
| May 31, 2013 | James M Shapiro | Director | Buy | $1.6M (692,711 @ $2.28) |
| May 31, 2013 | Roderick A Young | Director | Buy | $3.0M (1,311,086 @ $2.28) |
| May 31, 2013 | Russell C Hirsch | Director | Buy | $4.6M (2,009,806 @ $2.28) |
| May 31, 2013 | James M Shapiro | Director | Buy | $32K (14,129 @ $2.28) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.